Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Tom Solomon of the University of Liverpool’s Institute of Infection and Global Health gave the 5th Oxford Weatherall Lecture earlier this month.

Tom Solomon (centre) with his former tutor, Stephen Goss (left), and his former consultant, David Weatherall (right) (Photo: Jenny Morris)

The annual lecture is organised by the University of Oxford’s Medical Alumni Association in honour of Professor Sir David Weatherall, FRS, Emeritus Regius Professor of Medicine in Oxford. Solomon, who was one of Weatherall’s last house officers in 1990, spoke about the global threat of emerging brain infections. He described the work he started on Japanese encephalitis in Southeast Asia twenty-five years ago, and showed how the approaches he learnt then are now being applied to newer emerging infections such as Zika. Solomon is Director of the National institute for Health Research Health Protection Research Unit in Emerging and Zoonotic Infections which has been at the forefront of the UK research response to Zika, Ebola and other recent threats.

Solomon also reflected on how Weatherall had influenced him and a whole generation of clinical researchers, and recalled some of the patients he had cared for under Weatherall. This included world-famous author Roald Dahl, about whom Solomon has recently written a book.

Dr Stephen Goss, who introduced the lecture, had been Solomon’s Tutor in Medicine at Wadham College. He recalled Solomon’s admissions interview and their subsequent weekly tutorials, and he expressed his particular delight – and complete lack of surprise – that Solomon should now be invited back as a distinguished guest lecturer.

Afterwards Professor Weatherall, who is now in his 80s, commended Solomon for the progress made, but also highlighted the challenges ahead in working on emerging infections, and other imported diseases in tropical settings, such as the thalassaemia blood disorders.

Similar stories

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.